A Phase II Randomized Trial Evaluating Consolidative Nivolumab in Locally Advanced Non-Small Cell Lung Cancer Post Neoadjuvant Chemotherapy Plus Nivolumab and Concurrent Chemoradiotherapy (GASTO-1091).
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要